KCNIP1
KCNIP1 is a gene that encodes a member of the Kv channel-interacting protein (KCNIP) family. KCNIP family members are small calcium binding proteins. They all have N-terminal EF-hand domains, and are differentially expressed in many tissues. They bind to the voltage-gated potassium channels and may regulate their function. In particular, KCNIP1 is known to regulate neuronal excitability by interacting with Kv channels.
Structure[edit | edit source]
The KCNIP1 gene is located on the chromosome 5 (5q35.2-q35.3) and spans approximately 20 kb. The gene contains 8 exons and encodes a protein of 245 amino acids. The protein has a molecular weight of approximately 28 kDa. The protein contains four EF-hand calcium-binding motifs, which are located in the N-terminal half of the protein.
Function[edit | edit source]
KCNIP1 is a calcium sensor and potassium channel modulator. It has the ability to bind to the calcium ions and modulate the function of the voltage-gated potassium channels. This modulation affects the electrical properties of the neurons and other cells that express these channels. KCNIP1 is involved in the regulation of neuronal excitability, and it may play a role in the pathophysiology of epilepsy and other neurological disorders.
Clinical significance[edit | edit source]
Mutations in the KCNIP1 gene have been associated with various neurological disorders, including epilepsy, Alzheimer's disease, and schizophrenia. Studies have shown that the dysregulation of KCNIP1 expression may contribute to the pathogenesis of these disorders. However, the exact mechanisms by which KCNIP1 mutations contribute to these disorders are still not fully understood.
Research[edit | edit source]
Research on KCNIP1 is ongoing, with scientists trying to understand its exact role in the nervous system and how its dysregulation contributes to neurological disorders. This research may lead to the development of new therapeutic strategies for these disorders.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD